FirsthandHealth
medRxiv PreprintsInternational4 November 2026

PRISM-AD quantifies clinical and genetic contributions to cognitive risk prediction

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Background: Older adults with high inherited Alzheimer's disease (AD) susceptibility can still be cognitively normal (CN). An overall risk estimate alone does not show the cognitive and genetic contributions within a forecast. Objective: To quantify clinical and genetic contributions to cognitive prognosis. Methods: PRISM-AD combined nonlinear clinical functions and a polygenic risk score (PRS) term in 4,435 European-ancestry participants. Participant-level internal validation evaluated first recorded mild cognitive impairment (MCI) after CN in 908 participants and AD dementia after MCI in 714
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.